{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T23:08:15Z","timestamp":1772060895086,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82004203"],"award-info":[{"award-number":["82004203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82004203"],"award-info":[{"award-number":["82004203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82004203"],"award-info":[{"award-number":["82004203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82004203"],"award-info":[{"award-number":["82004203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82004203"],"award-info":[{"award-number":["82004203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82004203"],"award-info":[{"award-number":["82004203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82004203"],"award-info":[{"award-number":["82004203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82004203"],"award-info":[{"award-number":["82004203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82004203"],"award-info":[{"award-number":["82004203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82004203"],"award-info":[{"award-number":["82004203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["lzujbky-2021-ct06, lzujbky-2021-kb22"],"award-info":[{"award-number":["lzujbky-2021-ct06, lzujbky-2021-kb22"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["lzujbky-2021-ct06, lzujbky-2021-kb22"],"award-info":[{"award-number":["lzujbky-2021-ct06, lzujbky-2021-kb22"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["lzujbky-2021-ct06, lzujbky-2021-kb22"],"award-info":[{"award-number":["lzujbky-2021-ct06, lzujbky-2021-kb22"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["lzujbky-2021-ct06, lzujbky-2021-kb22"],"award-info":[{"award-number":["lzujbky-2021-ct06, lzujbky-2021-kb22"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["lzujbky-2021-ct06, lzujbky-2021-kb22"],"award-info":[{"award-number":["lzujbky-2021-ct06, lzujbky-2021-kb22"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["lzujbky-2021-ct06, lzujbky-2021-kb22"],"award-info":[{"award-number":["lzujbky-2021-ct06, lzujbky-2021-kb22"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["lzujbky-2021-ct06, lzujbky-2021-kb22"],"award-info":[{"award-number":["lzujbky-2021-ct06, lzujbky-2021-kb22"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["lzujbky-2021-ct06, lzujbky-2021-kb22"],"award-info":[{"award-number":["lzujbky-2021-ct06, lzujbky-2021-kb22"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["lzujbky-2021-ct06, lzujbky-2021-kb22"],"award-info":[{"award-number":["lzujbky-2021-ct06, lzujbky-2021-kb22"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["lzujbky-2021-ct06, lzujbky-2021-kb22"],"award-info":[{"award-number":["lzujbky-2021-ct06, lzujbky-2021-kb22"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-022-04261-0","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T12:08:23Z","timestamp":1666008503000},"page":"2263-2276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Probiotics therapy for adults with diarrhea-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 RCTs"],"prefix":"10.1007","volume":"37","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangfen","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangle","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenfen","family":"E","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoqun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kehu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"4261_CR1","unstructured":"Wald A, Talley N and Grover S (2014) Clinical manifestations and diagnosis of irritable bowel syndrome in adults. UpToDate, Waltham, MA. (Accessed on 01 Nov 2016)"},{"key":"4261_CR2","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","volume":"150","author":"F Mearin","year":"2016","unstructured":"Mearin F, Lacy B, Chang L (2016) Rome IV: the functional bowel disorders. Gastroenterology 150:1393\u20131407","journal-title":"Gastroenterology"},{"key":"4261_CR3","unstructured":"Health NIf and Excellence C (2017) Irritable bowel syndrome in adults: diagnosis and management. National Institute for Health and Care Excellence (NICE)"},{"key":"4261_CR4","doi-asserted-by":"crossref","unstructured":"Douglas A, Drossman et al (2016) Rome IV\u2013functional GI disorders: disorders of gut-brain interaction. Gastroenterology 150:1257\u20131261","DOI":"10.1053\/j.gastro.2016.03.035"},{"key":"4261_CR5","doi-asserted-by":"crossref","unstructured":"Cash BD, Lacy BE, Schoenfeld PS et al (2017) Safety of eluxadoline in patients with irritable bowel syndrome with diarrhea. Official J Am College Gastroenterol | ACG 112","DOI":"10.1038\/ajg.2016.542"},{"key":"4261_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1471-230X-12-104","volume":"12","author":"TW Yu","year":"2012","unstructured":"Yu TW, Lim HY, Tai D et al (2012) The impact of irritable bowel syndrome on health-related quality of life: a Singapore perspective. BMC Gastroenterol 12:104","journal-title":"BMC Gastroenterol"},{"key":"4261_CR7","doi-asserted-by":"publisher","first-page":"755","DOI":"10.18553\/jmcp.2013.19.9.755","volume":"19","author":"D Nellesen","year":"2013","unstructured":"Nellesen D, Yee K, Chawla A et al (2013) A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation. J Managed Care Pharm JMCP 19:755\u2013674","journal-title":"J Managed Care Pharm JMCP"},{"key":"4261_CR8","doi-asserted-by":"crossref","unstructured":"Canavan C, West J, Card T (2014) Review article: the economic impact of the irritable bowel syndrome. Alimentary Pharmacol Ther 40","DOI":"10.1111\/apt.12938"},{"key":"4261_CR9","unstructured":"Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol"},{"key":"4261_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1136\/gut.2006.100594","volume":"56","author":"M Guilarte","year":"2007","unstructured":"Guilarte M, Santos J, Torres ID et al (2007) Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 56:203\u2013209","journal-title":"Gut"},{"key":"4261_CR11","first-page":"164","volume":"10","author":"PA Hayes","year":"2014","unstructured":"Hayes PA, Fraher MH, Quigley E (2014) Irritable bowel syndrome: the role of food in pathogenesis and management. Gastroenterol Hepatol 10:164\u2013174","journal-title":"Gastroenterol Hepatol"},{"key":"4261_CR12","unstructured":"Camilleri M, Talley NJ, Travis AC (2000) Alosetron hydrochloride (Lotronex) for irritable bowel syndrome. Med Lett Drugs Ther 42:53\u201354"},{"key":"4261_CR13","doi-asserted-by":"crossref","unstructured":"IBS ACoGTFo (2009) Corrigendum: an evidence-based position statement on the management of irritable bowel syndrome. Official J Am College Gastroenterol | ACG 104","DOI":"10.1038\/ajg.2009.134"},{"key":"4261_CR14","doi-asserted-by":"crossref","unstructured":"Vahedi H, Merat S, Momtahen S et al (2010) Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome. Alimentary Pharmacol Ther 27","DOI":"10.1111\/j.1365-2036.2008.03633.x"},{"key":"4261_CR15","doi-asserted-by":"crossref","unstructured":"Ford AC, Lacy BE, Talley NJ (2017) Irritable bowel syndrome \u2013 NEJM","DOI":"10.1056\/NEJMra1607547"},{"key":"4261_CR16","unstructured":"Houte K, Colomier E, Schol J et al (2020) Recent advances in diagnosis and management of irritable bowel syndrome. Curr Opin Psychiatry. Publish Ahead of Print"},{"key":"4261_CR17","unstructured":"Maharaul MS, Rathod CC, Agrawal VM et al (2015) Probiotics for diarrhoea \u2013 predominant irritable bowel syndrome. Int J Res Med 4:68\u201370"},{"key":"4261_CR18","doi-asserted-by":"crossref","unstructured":"Abbas Z, Yakoob J, Jafri W et al (2014) Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome: a randomized trial. Eur J Gastroenterol Hepatol 26","DOI":"10.1097\/MEG.0000000000000094"},{"key":"4261_CR19","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.3390\/nu12071999","volume":"12","author":"B Skrzyd\u0142o-Radoma\u0144ska","year":"2020","unstructured":"Skrzyd\u0142o-Radoma\u0144ska B, Prozorow-Kr\u00f3l B, Cicho\u017c-Lach H et al (2020) The effectiveness of synbiotic preparation containing Lactobacillus and Bifidobacterium probiotic strains and short chain fructooligosaccharides in patients with diarrhea predominant irritable bowel syndrome\u2013a randomized double-blind, placebo-controlled study. Nutrients 12:1999","journal-title":"Nutrients"},{"key":"4261_CR20","doi-asserted-by":"crossref","unstructured":"Zhuang X, Xiong L, Li L et al (2016) Alterations of gut microbiota in patients with irritable bowel syndrome: a systematic review and meta\u2010analysis. J Gastroenterol Hepatol","DOI":"10.1111\/jgh.13471"},{"key":"4261_CR21","doi-asserted-by":"crossref","unstructured":"Bhattarai Y, Muniz Pedrogo DA, Kashyap PC (2017) Irritable bowel syndrome: a gut microbiota-related disorder? Am J Physiol Gastrointestinal Liver Physiol 312:G52\u2013G62","DOI":"10.1152\/ajpgi.00338.2016"},{"key":"4261_CR22","unstructured":"Belgin D, Facey B, Dogan EI et al (2018) Evaluation of Escherichia coli pathotypes associated with irritable bowel syndrome. FEMS Microbiol Lett 22"},{"key":"4261_CR23","doi-asserted-by":"publisher","first-page":"396S","DOI":"10.1093\/jn\/130.2.396S","volume":"130","author":"RD Rolfe","year":"2000","unstructured":"Rolfe RD (2000) The role of probiotic cultures in the control of gastrointestinal health. J Nutr 130:396S","journal-title":"J Nutr"},{"key":"4261_CR24","doi-asserted-by":"crossref","unstructured":"Fioramonti J, Theodorou V et al (2003) Probiotics: what are they? What are their effects on gut physiology? Best Pract Res Clin Gastroenterol 17:711\u2013724","DOI":"10.1016\/S1521-6918(03)00075-1"},{"key":"4261_CR25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/MCG.0b013e31823712b1","volume":"46","author":"BK Cha","year":"2012","unstructured":"Cha BK, Jung SM, Chang HC et al (2012) The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Clin Gastroenterol 46:220\u2013227","journal-title":"J Clin Gastroenterol"},{"key":"4261_CR26","doi-asserted-by":"crossref","unstructured":"Wu JC, Chan AO, Chan YW et al (2017) The current treatment landscape of irritable bowel syndrome in adults in Hong Kong: consensus statements. Hong Kong Med J Xianggang yi xue za zhi 23:641","DOI":"10.12809\/hkmj177060"},{"key":"4261_CR27","doi-asserted-by":"crossref","unstructured":"Song KH, Hye-Kyung J, Jin KH et al (2018) Clinical practice guidelines for irritable bowel syndrome in Korea, 2017 Revised Edition. J Neurogastroenterol Motil 24:197\u2013215","DOI":"10.5056\/jnm17145"},{"key":"4261_CR28","unstructured":"Study Group of Functional Gastrointestinal Disorders SGoGM (2020) Chinese Society of Gastroenterology, Chinese Medicine Association. Chinese expert consensus of irritable bowel syndrome in 2020. Chinese J Gastroenterol 40:16"},{"key":"4261_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00535-020-01746-z","volume":"56","author":"S Fukudo","year":"2021","unstructured":"Fukudo S, Okumura T, Inamori M et al (2021) Evidence-based clinical practice guidelines for irritable bowel syndrome 2020. J Gastroenterol 56:193\u2013217","journal-title":"J Gastroenterol"},{"key":"4261_CR30","doi-asserted-by":"crossref","unstructured":"Zeng J, Li Y-Q, Zuo XL et al (2008) Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome. Alimentary Pharmacol Ther 28:994\u20131002","DOI":"10.1111\/j.1365-2036.2008.03818.x"},{"key":"4261_CR31","first-page":"1","volume":"8","author":"Y-Y Sun","year":"2018","unstructured":"Sun Y-Y, Li M, Li Y-Y et al (2018) The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. Sci Rep 8:1\u201311","journal-title":"Sci Rep"},{"key":"4261_CR32","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/apt.15001","volume":"48","author":"AC Ford","year":"2018","unstructured":"Ford AC, Harris LA, Lacy BE et al (2018) Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther 48:1044\u20131060","journal-title":"Aliment Pharmacol Ther"},{"key":"4261_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/gut.2008.167270","volume":"59","author":"P Moayyedi","year":"2010","unstructured":"Moayyedi P, Ford AC, Talley NJ et al (2010) The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 59:325\u2013332","journal-title":"Gut"},{"key":"4261_CR34","doi-asserted-by":"crossref","unstructured":"Zhang Y, Li L, Guo C et al (2016) Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis. BMC Gastroenterol 16","DOI":"10.1186\/s12876-016-0470-z"},{"key":"4261_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001023","volume":"53","author":"R Francavilla","year":"2019","unstructured":"Francavilla R, Piccolo M, Francavilla A et al (2019) Clinical and microbiological effect of a multispecies probiotic supplementation in celiac patients with persistent IBS-type symptoms: a randomized, double-blind, placebo-controlled, multicenter trial. J Clin Gastroenterol 53:e117","journal-title":"J Clin Gastroenterol"},{"key":"4261_CR36","unstructured":"Sun JR, Kong CF, Qu XK et al (2019) Efficacy and safety of probiotics in irritable bowel syndrome: a systematic review and meta-analysis. Saudi J Gastroenterol 26"},{"key":"4261_CR37","doi-asserted-by":"crossref","unstructured":"Li B, Liang L, Deng H et al (2020) Efficacy and safety of probiotics in irritable bowel syndrome: a systematic review and meta-analysis. Front Pharmacol 11","DOI":"10.3389\/fphar.2020.00332"},{"key":"4261_CR38","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3390\/nu13030756","volume":"13","author":"B Skrzyd\u0142o-Radoma\u0144ska","year":"2021","unstructured":"Skrzyd\u0142o-Radoma\u0144ska B, Prozorow-Kr\u00f3l B, Cicho\u017c-Lach H et al (2021) The effectiveness and safety of multi-strain probiotic preparation in patients with diarrhea-predominant irritable bowel syndrome: a randomized controlled study. Nutrients 13:756","journal-title":"Nutrients"},{"key":"4261_CR39","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","volume":"130","author":"GF Longstreth","year":"2006","unstructured":"Longstreth GF, Thompson WG, Chey WD et al (2006) Functional bowel disorders. Gastroenterology 130:1480\u20131491","journal-title":"Gastroenterology"},{"key":"4261_CR40","doi-asserted-by":"crossref","unstructured":"Tao WW, Jiang H, Tao XM et al (2016) Effects of acupuncture, Tuina, Tai Chi, Qigong, and traditional Chinese medicine five-element music therapy on symptom management and quality of life for cancer patients: a meta-analysis. J Pain Symp Manage 728","DOI":"10.1016\/j.jpainsymman.2015.11.027"},{"key":"4261_CR41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/jebm.12384","volume":"13","author":"X Yao","year":"2020","unstructured":"Yao X, Florez ID, Zhang P et al (2020) Clinical research methods for treatment, diagnosis, prognosis, etiology, screening, and prevention: a narrative review. J Evid Based Med 13:130\u2013136","journal-title":"J Evid Based Med"},{"key":"4261_CR42","doi-asserted-by":"crossref","unstructured":"Guyatt G, Oxman AD, Akl EA et al (2011) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64:383\u2013394","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"4261_CR43","doi-asserted-by":"crossref","unstructured":"Bro\u017cek J, Akl EA, Alonso\u2010Coello P et al (2009) Grading quality of evidence and strength of recommendations in clinical practice guidelines: part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy 64:669\u2013677","DOI":"10.1111\/j.1398-9995.2009.01973.x"},{"key":"4261_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R Dersimonian","year":"1986","unstructured":"Dersimonian R, Nan L (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177","journal-title":"Control Clin Trials"},{"key":"4261_CR45","doi-asserted-by":"crossref","unstructured":"Higgins J, Thompson SG, Decks JJ et al (2003) Measuring inconsistency in meta-analyses. British Med J 327:557\u2013560","DOI":"10.1136\/bmj.327.7414.557"},{"key":"4261_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.18295\/squmj.2020.20.01.003","volume":"20","author":"MZ Asha","year":"2020","unstructured":"Asha MZ, Khalil S (2020) Efficacy and safety of probiotics, prebiotics and synbiotics in the treatment of irritable bowel syndrome: a systematic review and meta-analysis. Sultan Qaboos Univ Med J 20:13","journal-title":"Sultan Qaboos Univ Med J"},{"key":"4261_CR47","doi-asserted-by":"crossref","unstructured":"Li J, Mu Z, Xie J et al (2019) Effectiveness and safety of Chinese herbal medicine Xiaoyao San for the treatment of insomnia: protocol for a systematic review and meta-analysis. Medicine 98","DOI":"10.1097\/MD.0000000000016481"},{"key":"4261_CR48","doi-asserted-by":"crossref","unstructured":"Kim HJ et al (2003) A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Alimentary Pharmacol Ther 17:895\u2013904","DOI":"10.1046\/j.1365-2036.2003.01543.x"},{"key":"4261_CR49","doi-asserted-by":"crossref","unstructured":"Ishaque MS, Khosruzzaman SM, Ahmed DS et al (2018) A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult) in the management of diarrhea predominant irritable bowel syndrome. Meditsinskiy sovet Med Council 98\u2013108","DOI":"10.21518\/2079-701X-2018-14-98-108"},{"key":"4261_CR50","doi-asserted-by":"crossref","unstructured":"Skrzydo-Radoma\u0144ska B, Prozorow-Kr\u00f3l B, Cicho-Lach H et al (2021) The effectiveness and safety of multi-strain probiotic preparation in patients with diarrhea-predominant irritable bowel syndrome: a randomized controlled study. Nutrients 13","DOI":"10.3390\/nu13030756"},{"key":"4261_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12602-010-9059-y","volume":"3","author":"S Michail","year":"2011","unstructured":"Michail S, Kenche H (2011) Gut microbiota is not modified by randomized, double-blind, placebo-controlled trial of VSL# 3 in diarrhea-predominant irritable bowel syndrome. Probiotics Antimicrob Proteins 3:1\u20137","journal-title":"Probiotics Antimicrob Proteins"},{"key":"4261_CR52","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/MCG.0b013e318204593e","volume":"45","author":"CH Choi","year":"2011","unstructured":"Choi CH, Jo SY, Park HJ et al (2011) A randomized, double-blind, placebo-controlled multicenter trial of Saccharomyces boulardii in irritable bowel syndrome: effect on quality of life. J Clin Gastroenterol 45:679\u2013683","journal-title":"J Clin Gastroenterol"},{"key":"4261_CR53","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/MCG.0b013e318204593e","volume":"45","author":"HC Chang","year":"2011","unstructured":"Chang HC, Sun YJ, Park HJ et al (2011) A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life. J Clin Gastroenterol 45:679\u2013683","journal-title":"J Clin Gastroenterol"},{"key":"4261_CR54","doi-asserted-by":"crossref","unstructured":"Wilhelm SM, Brubaker CM, Varcak EA et al (2012) Effectiveness of probiotics in the treatment of irritable bowel syndrome. Pharmacotherapy 28","DOI":"10.1592\/phco.28.4.496"},{"key":"4261_CR55","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijsu.2020.04.063","volume":"79","author":"W Yong","year":"2020","unstructured":"Yong W, Jl B, Ql B et al (2020) The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: a systematic review and meta-analysis based on seventeen randomized controlled trials. Int J Surg 79:111\u2013119","journal-title":"Int J Surg"},{"key":"4261_CR56","doi-asserted-by":"crossref","unstructured":"Asha MZ, Khalil S (2020) Efficacy and safety of probiotics, prebiotics and synbiotics in the treatment of irritable bowel syndrome. SQU J Sci Res Med Sci 20","DOI":"10.18295\/squmj.2020.20.01.003"},{"key":"4261_CR57","doi-asserted-by":"crossref","unstructured":"Elfghi M, Jordan F, Sultan S et al (2020) Study within a trial protocol: same\u2010day consent vs. delayed consent in a randomized trial. J Evidence Based Med 13:246\u2013248","DOI":"10.1111\/jebm.12392"},{"key":"4261_CR58","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jclinepi.2016.01.003","volume":"74","author":"L Yao","year":"2016","unstructured":"Yao L, Sun R, Chen Y-L et al (2016) The quality of evidence in Chinese meta-analyses needs to be improved. J Clin Epidemiol 74:73\u201379","journal-title":"J Clin Epidemiol"},{"key":"4261_CR59","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jclinepi.2016.12.004","volume":"85","author":"J Tian","year":"2017","unstructured":"Tian J, Zhang J, Ge L et al (2017) The methodological and reporting quality of systematic reviews from China and the USA are similar. J Clin Epidemiol 85:50\u201358","journal-title":"J Clin Epidemiol"},{"key":"4261_CR60","doi-asserted-by":"crossref","unstructured":"Ge L, Tian J-H, Li Y-N et al (2018) Association between prospective registration and overall reporting and methodological quality of systematic reviews: a meta-epidemiological study can China master the guideline challenge? J Clin Epidemiol 93:45\u201355","DOI":"10.1016\/j.jclinepi.2017.10.012"},{"key":"4261_CR61","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.healthpol.2014.09.002","volume":"119","author":"L Xiu-xia","year":"2015","unstructured":"Xiu-xia L, Ya Z, Yao-long C et al (2015) The reporting characteristics and methodological quality of Cochrane reviews about health policy research. Health Policy 119:503\u2013510","journal-title":"Health Policy"},{"key":"4261_CR62","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jclinepi.2015.11.016","volume":"76","author":"J Li","year":"2016","unstructured":"Li J, Gao W, Punja S et al (2016) Reporting quality of N-of-1 trials published between 1985 and 2013: a systematic review. J Clin Epidemiol 76:57\u201364","journal-title":"J Clin Epidemiol"},{"key":"4261_CR63","doi-asserted-by":"crossref","unstructured":"Li Y, Cao L, Zhang Z et al (2021) Reporting and methodological quality of COVID-19 systematic reviews needs to be improved: an evidence mapping. J Clin Epidemiol","DOI":"10.1016\/j.jclinepi.2021.02.021"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-022-04261-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-022-04261-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-022-04261-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T10:03:36Z","timestamp":1667815416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-022-04261-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":63,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["4261"],"URL":"https:\/\/doi.org\/10.1007\/s00384-022-04261-0","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,17]]},"assertion":[{"value":"27 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}